C, K., A, M., N, F., SJ, V., MP, v. d. S., AH, M. d. Z., . . . DB, H. (2020). Pharmacogenomic associations of adverse drug reactions in asthma: Systematic review and research prioritisation. The pharmacogenomics journal, 20(5), 621. https://doi.org/10.1038/s41397-019-0140-y
Chicago Style (17th ed.) CitationC, King, et al. "Pharmacogenomic Associations of Adverse Drug Reactions in Asthma: Systematic Review and Research Prioritisation." The Pharmacogenomics Journal 20, no. 5 (2020): 621. https://doi.org/10.1038/s41397-019-0140-y.
MLA (9th ed.) CitationC, King, et al. "Pharmacogenomic Associations of Adverse Drug Reactions in Asthma: Systematic Review and Research Prioritisation." The Pharmacogenomics Journal, vol. 20, no. 5, 2020, p. 621, https://doi.org/10.1038/s41397-019-0140-y.